Updates about federal funding and UW Alzheimer’s disease research

This post updated March 7, 2025.

The Wisconsin Registry for Alzheimer’s Prevention, the Wisconsin Alzheimer’s Institute, and Wisconsin Alzheimer’s Disease Research Center receive federal funding through the National Institutes of Health (NIH).

To stay informed about federal funding changes that impact UW Alzheimer’s disease research programs, please visit the UW–Madison Office of Federal Relations updates page.

University of Wisconsin School of Medicine and Public Health Dean Robert N. Golden, MD, and Senior Associate Dean Anjon Audhya, PhD, spoke to news outlets about the funding cuts.

Interviews include:

Dr. Robert Golden on NIH funding and medical research at UW” – PBS Wisconsin, Feb. 14, 2025

NIH cuts could stall medical progress for lifesaving treatments, experts say – NBC News, Feb. 10, 2025

UW researcher warns that federal funding cuts could halt vital work” – Milwaukee WTMJ , Feb. 13, 2025

UW-Madison researchers warn funding cuts would delay new treatments for cancer, more” – Milwaukee Journal Sentinel, Feb. 20, 2025

Related news:

NIH funding drives life-saving innovation and economic impact in Wisconsin. University, biomedical and industry leaders issue call to protect it” – news.wisc.edu, March 7, 2025

March 6 Update on NIH indirect cost rates” – UW Office of Federal Relations, March 6, 2025

Trump administration delays Wisconsin research funds by withholding, canceling review meetings” – Wisconsin Public Radio, Feb. 25, 2025